Published in World J Gastroenterol on October 14, 2007
Diagnosis and management of polycystic liver disease. Nat Rev Gastroenterol Hepatol (2013) 1.46
Evaluation of hepatic cystic lesions. World J Gastroenterol (2013) 1.43
Isolated polycystic liver disease. Adv Chronic Kidney Dis (2010) 1.08
Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol (2013) 1.04
Renal dysfunction in chronic liver disease. Crit Care (2010) 1.03
Liver transplantation for polycystic liver with massive hepatomegaly: a case report. World J Gastroenterol (2009) 0.88
Current management of noninfectious hepatic cystic lesions: A review of the literature. World J Hepatol (2013) 0.83
Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease. Liver Int (2013) 0.80
Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease. PLoS One (2015) 0.79
Treatment of polycystic liver disease with resection-fenestration and a new classification. World J Gastroenterol (2008) 0.78
Laparoscopic surgery and polycystic liver disease: Clinicopathological features and new trends in management. J Minim Access Surg (2016) 0.75
Polycystic liver disease presenting with an exudative pleural effusion: a case report. J Med Case Rep (2012) 0.75
Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes. World J Gastroenterol (2016) 0.75
Autosomal dominant polycystic kidney disease. N Engl J Med (1993) 5.64
Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med (1992) 2.34
Polycystic disease of kidney and liver presenting in childhood. J Med Genet (1971) 2.27
Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis (1983) 2.22
Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. AJR Am J Roentgenol (1989) 2.09
Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation. Liver Transpl (2006) 2.04
The hepatic von Meyenburg complex: prevalence and association with hepatic and renal cysts among 2843 autopsies [corrected]. Mod Pathol (1996) 2.03
Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc (1990) 2.02
Treatment of non-parasitic cystic disease of the liver: a new approach to therapy with polycystic liver. Ann Surg (1968) 1.77
Laparoscopic management of benign solid and cystic lesions of the liver. Ann Surg (1999) 1.70
Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol (2000) 1.66
Liver transplantation for polycystic liver disease. Arch Surg (1990) 1.61
Laparoscopic management of symptomatic nonparasitic cysts of the liver. Indications and results. Ann Surg (1994) 1.60
Management and long-term follow-up of hepatic cysts. Am J Surg (2001) 1.57
Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology (1997) 1.45
Surgical management of nonparasitic cystic liver disease. Am J Surg (1991) 1.45
Clinical profile of autosomal dominant polycystic liver disease. Hepatology (2003) 1.37
Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology (1990) 1.36
Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. Gastroenterology (1995) 1.36
Highly symptomatic adult polycystic disease of the liver. A report of fifteen cases. J Hepatol (1987) 1.30
Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1. Am J Hum Genet (2000) 1.24
Percutaneous aspiration and alcohol sclerotherapy for symptomatic hepatic cysts. An alternative to surgical intervention. Ann Surg (1989) 1.20
Liver changes and complications in adult polycystic kidney disease. Adv Nephrol Necker Hosp (1985) 1.20
Tailoring the management of nonparasitic liver cysts. Ann Surg (1998) 1.17
Alcohol sclerotherapy of non-parasitic cysts of the liver. Br J Surg (1989) 1.13
Laparoscopic treatment of simple hepatic cysts and polycystic liver disease. Surg Endosc (2003) 1.12
Infected hepatic cyst. Hepatogastroenterology (2003) 1.12
Isolated polycystic liver disease as a distinct genetic disease, unlinked to polycystic kidney disease 1 and polycystic kidney disease 2. Hepatology (1996) 1.12
Adult polycystic disease of the liver. Br J Surg (1991) 1.08
Liver transplantation for polycystic liver disease. Liver Transpl (2001) 1.06
Adult polycystic liver disease: is fenestration the most adequate operation for long-term management? Ann Surg (1997) 1.06
Cystic dilatation of peribiliary glands in livers with adult polycystic disease and livers with solitary nonparasitic cysts: an autopsy study. Hepatology (1992) 1.05
Treatment of symptomatic congenital hepatic cysts with single-session percutaneous drainage and ethanol sclerosis: technique and outcome. J Vasc Interv Radiol (1997) 1.05
Laparoscopic liver surgery. A report on 28 patients. Surg Endosc (1998) 1.04
Results of combined and sequential liver-kidney transplantation. Liver Transpl (2003) 1.03
Laparoscopic fenestration in polycystic liver disease. Br J Surg (1996) 1.03
Liver transplantation for polycystic liver disease--indications and outcome. Transplant Proc (2003) 1.02
Therapeutic dilemmas in patients with symptomatic polycystic liver disease. Am Surg (1988) 1.00
Massive hepatomegaly in adult polycystic liver disease. Am J Surg Pathol (1988) 1.00
Nonparasitic cysts of the liver: results and options of surgical treatment. World J Surg (1997) 0.99
The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch Pathol Lab Med (1990) 0.99
Surgery for adult polycystic liver disease. Surgery (1995) 0.98
Non-parasitic liver cysts and polycystic liver disease: results of surgical treatment. Hepatogastroenterology (1993) 0.97
Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease. Clin Nephrol (1997) 0.95
Combined cystic disease of the liver and kidney. Semin Liver Dis (1994) 0.94
Liver and kidney transplantation for polycystic disease. Transplantation (1998) 0.94
Adult polycystic liver and kidney diseases are separate entities. Clin Genet (1986) 0.94
Combined hepatic resection with fenestration for highly symptomatic polycystic liver disease: A report on seven patients. World J Gastroenterol (2004) 0.93
Fenestration in the management of polycystic liver disease. World J Surg (1995) 0.93
Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment. Gut (1995) 0.93
Liver transplantation for adult polycystic liver disease. Hepatology (1998) 0.91
Polycystic disease of the liver. Am J Gastroenterol (1958) 0.90
Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease. Hepatology (2004) 0.90
Isolated polycystic liver disease not linked to polycystic kidney disease 1 and 2. Dig Dis Sci (1999) 0.89
Continuous epithelial cell lines from ADPKD liver cysts exhibit characteristics of intrahepatic biliary epithelium. Am J Physiol (1995) 0.88
The microanatomy of the intrahepatic bile duct in polycystic disease: comparison of the cpk mouse and human. J Exp Pathol (Oxford) (1990) 0.86
Liver transplantation for adult polycystic liver disease. Liver Transpl Surg (1996) 0.84
Infection of hepatic cysts in polycystic disease. World J Surg (1984) 0.84
Autosomal dominant polycystic kidney disease with liver and pancreatic involvement in early childhood. Am J Kidney Dis (1989) 0.84
Screening for cerebral aneurysm in patients with polycystic liver disease. South Med J (1999) 0.81
Living-donor liver transplantation for polycystic liver disease. Transplantation (2004) 0.81
[Liver resection in patients with polycystic liver disease]. Gastroenterol Clin Biol (1998) 0.81
Liver transplantation in patients with polycystic liver disease. Transplant Proc (1997) 0.80
Autosomal dominant polycystic liver disease: a second family. Clin Genet (1982) 0.80
Living related liver transplantation for polycystic liver disease. Transpl Int (2002) 0.79
Obstructive jaundice associated with polycystic liver disease. HPB Surg (1996) 0.79
Successful living donor liver transplantation for polycystic liver in a patient with autosomal-dominant polycystic kidney disease. J Clin Gastroenterol (2001) 0.76
Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol (2003) 3.18
Diagnosis and treatment of cholangiocarcinoma. Oncologist (2004) 2.00
Effective treatment of biliary cystadenoma. Ann Surg (2005) 1.83
Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg (2004) 1.77
The impact of aviation-based teamwork training on the attitudes of health-care professionals. J Am Coll Surg (2004) 1.55
Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients. Transplantation (2006) 1.54
Pre-transplant overweight and obesity do not affect physical quality of life after kidney transplantation. J Am Coll Surg (2010) 1.51
Long-term detrimental effect of bile duct injury on health-related quality of life. Arch Surg (2004) 1.49
The long-term effect of bile duct injuries on health-related quality of life: a meta-analysis. HPB (Oxford) (2012) 1.30
Creating an emergency general surgery service enhances the productivity of trauma surgeons, general surgeons and the hospital. J Trauma (2005) 1.23
Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle. Arch Surg (2009) 1.19
The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg (2003) 1.12
Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality? Arch Surg (2007) 1.12
Liver and intestine transplantation: summary analysis, 1994-2003. Am J Transplant (2005) 1.09
Management of hepatocellular carcinoma. J Gastrointest Surg (2006) 1.07
Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. J Hepatobiliary Pancreat Surg (2004) 1.07
Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg (2005) 0.99
Survival after pediatric liver transplantation: why does living donation offer an advantage? Arch Surg (2005) 0.98
A cost-effectiveness analysis of early vs late reconstruction of iatrogenic bile duct injuries. J Am Coll Surg (2012) 0.94
Liver transplantation for non-hepatocellular carcinoma malignancy. HPB (Oxford) (2007) 0.93
Liver transplantation for iatrogenic porta hepatis transection. Am Surg (2009) 0.91
The impact of tumor extent (T stage) and lymph node involvement (N stage) on survival after surgical resection for gallbladder adenocarcinoma. HPB (Oxford) (2008) 0.91
Is there racial disparity in outcomes after solid organ transplantation? Am J Surg (2004) 0.89
Reversed activity of mitochondrial adenine nucleotide translocator in ischemia-reperfusion. Transplantation (2003) 0.89
The effects of physical quality of life, time, and gender on change in symptoms of anxiety and depression after liver transplantation. J Gastrointest Surg (2007) 0.89
Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg (2006) 0.88
A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables. J Am Coll Surg (2008) 0.88
Correlation of health-related quality of life after liver transplant with the Model for End-Stage Liver Disease score. Arch Surg (2009) 0.88
Reduction in corticosteroids is associated with better health-related quality of life after liver transplantation. J Am Coll Surg (2011) 0.87
Health insurance status affects staging and influences treatment strategies in patients with hepatocellular carcinoma. Ann Surg Oncol (2010) 0.87
Novel role of phospholipase C-delta1: regulation of liver mitochondrial Ca2+ uptake. Am J Physiol Gastrointest Liver Physiol (2004) 0.85
Donor conversion and organ yield in traumatic brain injury patients: missed opportunities and missed organs. J Trauma (2008) 0.85
Effects of hepatitis C virus infection and its recurrence after liver transplantation on functional performance and health-related quality of life. J Gastrointest Surg (2002) 0.84
11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma. J Nucl Med (2003) 0.84
Mitochondrial P2Y-Like receptors link cytosolic adenosine nucleotides to mitochondrial calcium uptake. J Cell Biochem (2004) 0.84
Biliary reconstruction is enhanced with a collagen-polyethylene glycol sealant. Am Surg (2002) 0.84
Modeling the effects of functional performance and post-transplant comorbidities on health-related quality of life after heart transplantation. J Heart Lung Transplant (2003) 0.83
Ciliated hepatic foregut cysts in children. Pediatr Surg Int (2009) 0.83
Incorporating quality of life and patient satisfaction measures into a transplant outcomes assessment program: technical and practical considerations. Prog Transplant (2007) 0.82
A clinical comparative analysis of crush/clamp, stapler, and dissecting sealer hepatic transection methods. HPB (Oxford) (2008) 0.82
The Vanderbilt EvidenceWeb - developing tools to monitor and improve compliance with evidence-based order sets. AMIA Annu Symp Proc (2006) 0.82
Mitochondrial calcium uptake regulates cold preservation-induced Bax translocation and early reperfusion apoptosis. Am J Transplant (2004) 0.81
Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria? HPB (Oxford) (2011) 0.81
Continuous versus interrupted suture for end-to-end biliary anastomosis during liver transplantation gives equal results. Liver Transpl (2007) 0.81
Refining a health-related quality of life assessment strategy for solid organ transplant patients. Clin Transplant (2004) 0.79
Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer. Arch Surg (2009) 0.79
Survival and quality of life after organ transplantation in veterans and nonveterans. Am J Surg (2003) 0.79
Validation of the Written Administration of the Short Literacy Survey. J Health Commun (2015) 0.79
Drain use after open cholecystectomy: is there a justification? Langenbecks Arch Surg (2009) 0.78
Negative effects of pretransplant body mass index on physical health-related quality of life after lung transplant. Prog Transplant (2012) 0.78
Effects of clinical factors on psychosocial variables in renal transplant recipients. J Adv Nurs (2009) 0.78
Liver transplantation is not indicated for cholangiocarcinoma. HPB (Oxford) (2003) 0.77
Real-time spectroscopic assessment of thermal damage: implications for radiofrequency ablation. J Gastrointest Surg (2004) 0.77
Water warming garment versus forced air warming system in prevention of intraoperative hypothermia during liver transplantation: a randomized controlled trial [ISRCTN32154832]. BMC Anesthesiol (2002) 0.77
Profile of health-related quality of life outcomes after liver transplantation: univariate effects and multivariate models. HPB (Oxford) (2008) 0.77
Altered ATP-dependent mitochondrial Ca2+ uptake in cold ischemia is attenuated by ruthenium red. J Surg Res (2003) 0.77
The validity of EQ-5D US preference weights in liver transplant candidates and recipients. Liver Transpl (2009) 0.76
Exsanguination protocol improves survival after major hepatic trauma. Injury (2010) 0.76
Effects of diabetes and cadaveric organs on functional performance and health-related quality of life after kidney transplantation. Am J Surg (2003) 0.75
An urban-rural blight? Choledocholithiasis presentation and treatment. J Surg Res (2011) 0.75
Contralateral portal vein embolization for hepatectomy in the setting of hepatic steatosis. Am Surg (2004) 0.75
Physician predictions of graft survival following liver transplantation. HPB (Oxford) (2007) 0.75
Reply to Domínguez-Rosado et al. HPB (Oxford) (2014) 0.75
Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death? HPB (Oxford) (2012) 0.75
Access to pediatric liver transplantation: does regional variation play a role? J Gastrointest Surg (2006) 0.75
Orthotopic liver transplant and hepatic resection: Lessons learned from complimentary disciplines. Curr Surg (2005) 0.75
Comparison of open live donor nephrectomy, laparoscopic live donor nephrectomy, and hand-assisted live donor nephrectomy: a cost-minimization analysis. J Surg Res (2012) 0.75